⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STTK News
Shattuck Labs, Inc. Common Stock
Form 8-K
sec.gov
STTK
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
STTK
Form 8-K
sec.gov
STTK
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
globenewswire.com
STTK
Form 8-K
sec.gov
STTK
Shattuck Labs, Inc. Announces Proposed Public Offering
globenewswire.com
STTK
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update
globenewswire.com
STTK
Shattuck Labs Announces Phase 1 Results for SL-325
globenewswire.com
STTK
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
globenewswire.com
STTK
Form 8-K
sec.gov
STTK